COR

COR

USD

Cencora Inc. Common Stock

$344.530+6.270 (1.854%)

リアルタイム価格

Healthcare
Medical Distribution
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$338.260

高値

$347.350

安値

$335.905

出来高

2.82M

企業ファンダメンタルズ

時価総額

66.8B

業種

Medical Distribution

United States

取引統計

平均出来高

1.44M

取引所

NYQ

通貨

USD

52週レンジ

安値 $223.92現在値 $344.530高値 $350.46

AI分析レポート

最終更新: 2025年11月3日
AIによる生成データソース: Yahoo Finance, Bloomberg, SEC

Cencora (COR) on a Tear: Riding a Wave of Analyst Upgrades to New Highs

November 03, 2025, 01:45 PM EDT

The Drumbeat of Approval: Analysts Cheer Cencora Forward

The news surrounding Cencora is decidedly upbeat. In the last week of October, two influential firms signaled their confidence in the company's direction. First, UBS maintained its Buy rating and gave its price target a significant boost, moving it from $350 all the way to $380. Just a few days later, Mizuho followed suit, reiterating an Outperform rating and nudging its own target up to $340. This kind of back-to-back positive reinforcement from analysts often catches the market's attention, and it appears to be a key ingredient in the stock's recent performance.

The Anatomy of a Rally: Charting COR's Explosive Climb

Looking at the price chart for the past three months tells a clear story of building momentum. After a choppy August and September that saw the stock trade in a wide range between roughly $273 and $312, October was a different beast entirely. The stock began a powerful and sustained climb, breaking through previous resistance levels. This ascent culminated in a surge to a new 52-week high of $350.46 on October 30th, a move accompanied by a dramatic spike in trading volume. While the stock pulled back slightly to close the month at $337.81, the overall trend is unmistakably upward. This isn't a slow grind; it's an aggressive move higher, suggesting strong conviction from buyers.

Digital Crystal Ball: What the AI Sees for Cencora's Next Move

The algorithmic forecast aligns with the bullish sentiment seen in the news and on the charts. Projections for the immediate future are positive, suggesting the upward momentum could continue. The model anticipates a sequence of gains over the next three trading sessions:

  • Day 1: +1.20%
  • Day 2: +2.23%
  • Day 3: +3.10%

This AI-driven outlook, which is stated to have high confidence, points toward a continuation of the recent trend. It suggests that the slight pullback from the recent peak might be temporary, with more strength potentially on the horizon.

The Bottom Line

Cencora is currently displaying all the signs of a stock with powerful momentum. Positive analyst upgrades appear to be fueling a strong technical breakout, and predictive models expect the run to continue in the very near term. The company's high Return on Equity is a notable fundamental strength.

However, investors should be aware of the risks. The company carries a very high level of debt relative to its equity, a factor that cannot be ignored. Furthermore, the stock just came off a new 52-week high and could be prone to volatility as traders take profits.

For a medium-term investor comfortable with these risks, the data suggests a strategy of engaging with the current trend. A potential entry point could be considered around the $339 level. To manage the risk of a sharp reversal, a stop-loss near $304 seems prudent. If the stock continues its upward trajectory, taking profits around the $344.50 mark could be a reasonable first target.


Disclaimer: This report is for informational purposes only and does not constitute financial advice, an offer to sell, or a solicitation of an offer to buy any security. The analysis is based solely on the data provided and may not be comprehensive. Investing in stocks involves risks, including the possible loss of principal. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

関連ニュース

Analyst Upgrades

Mizuho Maintains Outperform on Cencora, Raises Price Target to $340

Mizuho analyst Steven Valiquette maintains Cencora with a Outperform and raises the price target from $334 to $340.

もっと見る
Mizuho Maintains Outperform on Cencora, Raises Price Target to $340
Analyst Upgrades

UBS Maintains Buy on Cencora, Raises Price Target to $380

UBS analyst Kevin Caliendo maintains Cencora with a Buy and raises the price target from $350 to $380.

もっと見る
UBS Maintains Buy on Cencora, Raises Price Target to $380

AI予測Beta

AI推奨

強気

更新日時: 2025年11月5日 04:09

弱気中立強気

66.7% 信頼度

リスクと取引

リスクレベル3/5
中リスク
適しているのは
保守的
取引ガイド

エントリーポイント

$346.14

利確

$351.53

損切り

$310.18

主要因子

DMIは弱気トレンドを示しており (ADX:10.6、+DI:4.3、-DI:7.3)、注意が必要です
現在の価格はサポートレベル(345.46ドル)に非常に接近しており、強力な買い機会を示唆しています
出来高は平均(11,776)の12.1倍で、極めて強い買い圧力を示しています
MACD -0.1665はシグナルライン-0.0178の下にあり、弱気クロスオーバーを示しています

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。